Literature DB >> 32287513

[Colombia need a modern national epidemiological surveillance system and to enlarge the use of molecular diagnosis in infectious diseases].

Jorge Enrique Gómez Marín1,2.   

Abstract

Entities:  

Year:  2014        PMID： 32287513      PMCID： PMC7133574          DOI： 10.1016/j.infect.2014.06.003

Source DB:  PubMed          Journal:  Infectio        ISSN： 0123-9392


× No keyword cloud information.
  6 in total

Review 1.  Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Karen R Steingart; Hojoon Sohn; Ian Schiller; Lorie A Kloda; Catharina C Boehme; Madhukar Pai; Nandini Dendukuri
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

2.  High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance.

Authors:  Q He; A M Barkoff; J Mertsola; S Glismann; S Bacci
Journal:  Euro Surveill       Date:  2012-08-09

3.  Multicenter feasibility study to assess external quality assessment panels for Xpert MTB/RIF assay in South Africa.

Authors:  Lesley Scott; Heidi Albert; Chris Gilpin; Heather Alexander; Kyle DeGruy; Wendy Stevens
Journal:  J Clin Microbiol       Date:  2014-04-30       Impact factor: 5.948

4.  Estimation of influenza vaccine effectiveness from routine surveillance data.

Authors:  Heath Kelly; Kylie Carville; Kristina Grant; Peter Jacoby; Thomas Tran; Ian Barr
Journal:  PLoS One       Date:  2009-03-31       Impact factor: 3.240

5.  Surveillance of pneumococcal serotype 1 carriage during an outbreak of serotype 1 invasive pneumococcal disease in central Australia 2010-2012.

Authors:  Jana Yr Lai; Heather Cook; Teem-Wing Yip; Jeanette Berthelsen; Stephen Gourley; Vicki Krause; Helen Smith; Amanda J Leach; Heidi Smith-Vaughan
Journal:  BMC Infect Dis       Date:  2013-09-03       Impact factor: 3.090

Review 6.  The challenge of emerging and re-emerging infectious diseases.

Authors:  David M Morens; Gregory K Folkers; Anthony S Fauci
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.